All In Biotech

Free tool

FAERS Monitor: Yonsa

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 210308 or its brand name (Yonsa, Abiraterone Acetate). Reports on generic versions are filed under their own applications.

Reports

6,863

Serious

5,670

83% of reports

Hospitalization

2,967

Death reported

1,274

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • death751
  • fatigue513
  • hot flush294
  • asthenia279
  • anaemia247
  • hypokalaemia240
  • diarrhoea217
  • prostatic specific antigen increased217
  • disease progression215
  • drug ineffective213
  • prostate cancer210
  • pneumonia208
  • fall206
  • hypertension206
  • therapy interrupted204

Reports by year received

View as table
YearReports
201013
2011119
2012213
2013123
2014214
2015199
2016161
2017203
2018267
2019514
2020728
2021541
2022788
2023834
2024579
2025852
2026515

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,296 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
prostatic specific antigen increasedSignal21749.043.010,008
hypokalaemiaSignal24016.014.13,353
hot flushSignal29412.010.72,952
therapy interruptedSignal2048.87.71,397
prostate cancerSignal2108.07.01,285
disease progressionSignal2155.64.9806
anaemiaSignal2474.03.5551
hypertensionSignal2063.02.6272
deathSignal7512.72.5818
astheniaSignal2792.32.0202
fatigueSignal5132.01.9273
pneumonia2082.01.7100
fall2061.91.788
diarrhoea2171.00.90
drug ineffective2130.50.4116

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.